company background image
ERGO

Ergomed AIM:ERGO Stock Report

Last Price

UK£12.52

Market Cap

UK£629.8m

7D

4.3%

1Y

12.8%

Updated

06 Feb, 2023

Data

Company Financials +

ERGO Stock Overview

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia.

ERGO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Ergomed plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ergomed
Historical stock prices
Current Share PriceUK£12.52
52 Week HighUK£14.78
52 Week LowUK£9.10
Beta0.85
1 Month Change-2.49%
3 Month Change-1.42%
1 Year Change12.79%
3 Year Change173.96%
5 Year Change526.00%
Change since IPO670.46%

Recent News & Updates

Recent updates

Ergomed plc (LON:ERGO) Shares Could Be 21% Below Their Intrinsic Value Estimate

Oct 29
Ergomed plc (LON:ERGO) Shares Could Be 21% Below Their Intrinsic Value Estimate

Should You Be Adding Ergomed (LON:ERGO) To Your Watchlist Today?

Jul 14
Should You Be Adding Ergomed (LON:ERGO) To Your Watchlist Today?

Why Ergomed plc (LON:ERGO) Could Be Worth Watching

Jun 12
Why Ergomed plc (LON:ERGO) Could Be Worth Watching

Calculating The Fair Value Of Ergomed plc (LON:ERGO)

Apr 07
Calculating The Fair Value Of Ergomed plc (LON:ERGO)

Does Ergomed (LON:ERGO) Deserve A Spot On Your Watchlist?

Mar 19
Does Ergomed (LON:ERGO) Deserve A Spot On Your Watchlist?

Why Ergomed plc (LON:ERGO) Could Be Worth Watching

Mar 01
Why Ergomed plc (LON:ERGO) Could Be Worth Watching

Calculating The Fair Value Of Ergomed plc (LON:ERGO)

Dec 15
Calculating The Fair Value Of Ergomed plc (LON:ERGO)

I Ran A Stock Scan For Earnings Growth And Ergomed (LON:ERGO) Passed With Ease

Nov 24
I Ran A Stock Scan For Earnings Growth And Ergomed (LON:ERGO) Passed With Ease

Calculating The Intrinsic Value Of Ergomed plc (LON:ERGO)

Aug 28
Calculating The Intrinsic Value Of Ergomed plc (LON:ERGO)

If You Like EPS Growth Then Check Out Ergomed (LON:ERGO) Before It's Too Late

Jul 31
If You Like EPS Growth Then Check Out Ergomed (LON:ERGO) Before It's Too Late

Getting In Cheap On Ergomed plc (LON:ERGO) Might Be Difficult

Jul 06
Getting In Cheap On Ergomed plc (LON:ERGO) Might Be Difficult

Ergomed plc (LON:ERGO) Shares Could Be 31% Above Their Intrinsic Value Estimate

May 21
Ergomed plc (LON:ERGO) Shares Could Be 31% Above Their Intrinsic Value Estimate

Do Ergomed's (LON:ERGO) Earnings Warrant Your Attention?

Mar 26
Do Ergomed's (LON:ERGO) Earnings Warrant Your Attention?

If You Had Bought Ergomed (LON:ERGO) Stock Five Years Ago, You Could Pocket A 643% Gain Today

Feb 22
If You Had Bought Ergomed (LON:ERGO) Stock Five Years Ago, You Could Pocket A 643% Gain Today

Has Ergomed plc's (LON:ERGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Jan 18
Has Ergomed plc's (LON:ERGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Ergomed plc's (LON:ERGO) Intrinsic Value Is Potentially 20% Below Its Share Price

Dec 13
Ergomed plc's (LON:ERGO) Intrinsic Value Is Potentially 20% Below Its Share Price

We Think Ergomed's (LON:ERGO) Statutory Profit Might Understate Its Earnings Potential

Nov 23
We Think Ergomed's (LON:ERGO) Statutory Profit Might Understate Its Earnings Potential

Shareholder Returns

ERGOGB Life SciencesGB Market
7D4.3%2.8%0.8%
1Y12.8%-39.7%-4.6%

Return vs Industry: ERGO exceeded the UK Life Sciences industry which returned -36.1% over the past year.

Return vs Market: ERGO exceeded the UK Market which returned -3.7% over the past year.

Price Volatility

Is ERGO's price volatile compared to industry and market?
ERGO volatility
ERGO Average Weekly Movement4.7%
Life Sciences Industry Average Movement7.2%
Market Average Movement5.1%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.7%

Stable Share Price: ERGO is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ERGO's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,371n/ahttps://www.ergomedplc.com

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies.

Ergomed plc Fundamentals Summary

How do Ergomed's earnings and revenue compare to its market cap?
ERGO fundamental statistics
Market CapUK£629.77m
Earnings (TTM)UK£13.36m
Revenue (TTM)UK£132.46m

47.2x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ERGO income statement (TTM)
RevenueUK£132.46m
Cost of RevenueUK£58.37m
Gross ProfitUK£74.09m
Other ExpensesUK£60.73m
EarningsUK£13.36m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.27
Gross Margin55.93%
Net Profit Margin10.08%
Debt/Equity Ratio0%

How did ERGO perform over the long term?

See historical performance and comparison